RADIA: RNA and DNA integrated analysis for somatic mutation detection.

The detection of somatic single nucleotide variants is a crucial component to the characterization of the cancer genome. Mutation calling algorithms thus far have focused on comparing the normal and tumor genomes from the same individual. In recent years, it has become routine for projects like The...

Full description

Bibliographic Details
Main Authors: Amie J Radenbaugh, Singer Ma, Adam Ewing, Joshua M Stuart, Eric A Collisson, Jingchun Zhu, David Haussler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4236012?pdf=render
id doaj-c741c31797964283b41975025a736376
record_format Article
spelling doaj-c741c31797964283b41975025a7363762020-11-25T01:01:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11151610.1371/journal.pone.0111516RADIA: RNA and DNA integrated analysis for somatic mutation detection.Amie J RadenbaughSinger MaAdam EwingJoshua M StuartEric A CollissonJingchun ZhuDavid HausslerThe detection of somatic single nucleotide variants is a crucial component to the characterization of the cancer genome. Mutation calling algorithms thus far have focused on comparing the normal and tumor genomes from the same individual. In recent years, it has become routine for projects like The Cancer Genome Atlas (TCGA) to also sequence the tumor RNA. Here we present RADIA (RNA and DNA Integrated Analysis), a novel computational method combining the patient-matched normal and tumor DNA with the tumor RNA to detect somatic mutations. The inclusion of the RNA increases the power to detect somatic mutations, especially at low DNA allelic frequencies. By integrating an individual's DNA and RNA, we are able to detect mutations that would otherwise be missed by traditional algorithms that examine only the DNA. We demonstrate high sensitivity (84%) and very high precision (98% and 99%) for RADIA in patient data from endometrial carcinoma and lung adenocarcinoma from TCGA. Mutations with both high DNA and RNA read support have the highest validation rate of over 99%. We also introduce a simulation package that spikes in artificial mutations to patient data, rather than simulating sequencing data from a reference genome. We evaluate sensitivity on the simulation data and demonstrate our ability to rescue back mutations at low DNA allelic frequencies by including the RNA. Finally, we highlight mutations in important cancer genes that were rescued due to the incorporation of the RNA.http://europepmc.org/articles/PMC4236012?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Amie J Radenbaugh
Singer Ma
Adam Ewing
Joshua M Stuart
Eric A Collisson
Jingchun Zhu
David Haussler
spellingShingle Amie J Radenbaugh
Singer Ma
Adam Ewing
Joshua M Stuart
Eric A Collisson
Jingchun Zhu
David Haussler
RADIA: RNA and DNA integrated analysis for somatic mutation detection.
PLoS ONE
author_facet Amie J Radenbaugh
Singer Ma
Adam Ewing
Joshua M Stuart
Eric A Collisson
Jingchun Zhu
David Haussler
author_sort Amie J Radenbaugh
title RADIA: RNA and DNA integrated analysis for somatic mutation detection.
title_short RADIA: RNA and DNA integrated analysis for somatic mutation detection.
title_full RADIA: RNA and DNA integrated analysis for somatic mutation detection.
title_fullStr RADIA: RNA and DNA integrated analysis for somatic mutation detection.
title_full_unstemmed RADIA: RNA and DNA integrated analysis for somatic mutation detection.
title_sort radia: rna and dna integrated analysis for somatic mutation detection.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The detection of somatic single nucleotide variants is a crucial component to the characterization of the cancer genome. Mutation calling algorithms thus far have focused on comparing the normal and tumor genomes from the same individual. In recent years, it has become routine for projects like The Cancer Genome Atlas (TCGA) to also sequence the tumor RNA. Here we present RADIA (RNA and DNA Integrated Analysis), a novel computational method combining the patient-matched normal and tumor DNA with the tumor RNA to detect somatic mutations. The inclusion of the RNA increases the power to detect somatic mutations, especially at low DNA allelic frequencies. By integrating an individual's DNA and RNA, we are able to detect mutations that would otherwise be missed by traditional algorithms that examine only the DNA. We demonstrate high sensitivity (84%) and very high precision (98% and 99%) for RADIA in patient data from endometrial carcinoma and lung adenocarcinoma from TCGA. Mutations with both high DNA and RNA read support have the highest validation rate of over 99%. We also introduce a simulation package that spikes in artificial mutations to patient data, rather than simulating sequencing data from a reference genome. We evaluate sensitivity on the simulation data and demonstrate our ability to rescue back mutations at low DNA allelic frequencies by including the RNA. Finally, we highlight mutations in important cancer genes that were rescued due to the incorporation of the RNA.
url http://europepmc.org/articles/PMC4236012?pdf=render
work_keys_str_mv AT amiejradenbaugh radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT singerma radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT adamewing radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT joshuamstuart radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT ericacollisson radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT jingchunzhu radiarnaanddnaintegratedanalysisforsomaticmutationdetection
AT davidhaussler radiarnaanddnaintegratedanalysisforsomaticmutationdetection
_version_ 1725208049109434368